YMR-10393-77893
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 064 / CT
- Registered
- 2022-07-19
- Relationship
- Child or adolescent in my care
- Guardian
- H83-23659-00038
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-19
Registered in v-safe
-
2022-07-19
Dose 1 — Pfizer-BioNTech
- 2022-07-19
-
2022-07-20
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Redness, Swelling/hardness · NoneUnder 3 check-in
- 2022-07-21
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-08-02
-
2022-08-09
Dose 2 — Pfizer-BioNTech
- 2022-08-10
- 2022-08-11
- 2022-08-12
- 2022-08-13
- 2022-08-16
-
2022-11-08
Survey response — 3 months, dose 2, under 3MedDRA: Office visit, Roseola — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Roseola · Healthcare visit (other): In person visitMedDRA releases: 2024-11 · check-in free text available
-
2022-11-08
Report sent to call center — 3 months, dose 2, under 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-11-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-19 | Pfizer-BioNTech | No |
| 2 | 2022-08-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Roseola | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release